Shanghai Henlius Biotech, Inc.
Shanghai Henlius Biotech, Inc. (China) holds 2 active US FDA Type II Drug Master Files. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Shanghai Henlius Biotech, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/shanghai-henlius-biotech-inc
Overview
Shanghai Henlius Biotech, Inc. is a leading biopharmaceutical company specializing in the development and commercialization of monoclonal antibody drugs. Henlius is renowned for its high-quality biosimilar products, as well as its innovative pipeline of novel therapies targeting cancer and autoimmune diseases.
Core services & business areas
Therapeutic areas
API / Drug Master Files
Shanghai Henlius Biotech, Inc. holds 2 active (2 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- MANUFACTURING & CONTROL OF RHUPH20Active2026-03-10
- MANUFACTURING AND CONTROL OF RHUPH20Active2025-10-24
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Shanghai Henlius Biotech, Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Shanghai Henlius Biotech, Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.